Did Trump claim he would go through the FDA to ban abortions federally?
ChatGPT said:
ChatGPT
Searched 3 sites
Donald Trump has not explicitly stated that he would go through the FDA to ban abortions federally. However, there have been discussions and proposals that suggest a potential approach involving the FDA. Specifically, Trump has hinted that his administration might reconsider the FDA’s approval of mifepristone, a drug commonly used for medication abortions, which could lead to its removal from the market. This action would have nationwide implications, even in states where abortion is legal.
These discussions are part of broader proposals like Project 2025, which outlines various conservative strategies for a potential second Trump administration. This includes revisiting the approval of abortion medications and imposing stricter regulations that could effectively limit access to abortion across the country, without needing a federal ban passed through Congress.
While Trump himself has been somewhat vague on the details, the pressure from anti-abortion groups and his track record suggest that his administration could pursue these regulatory strategies to curtail abortion access at the federal level (The 19th) (KFF Health News).
4o
You said:
When was the last time you can find that Trump hinted at this reconsideration?
ChatGPT said:
ChatGPT
The most recent time Donald Trump hinted at reconsidering the FDA’s approval of mifepristone, a key drug used in medication abortions, was in August 2024. This came up in the context of the broader “Project 2025” proposals, which outline potential actions a future Trump administration could take regarding abortion. Specifically, these proposals include revisiting the approval of mifepristone and potentially withdrawing it, which would significantly impact abortion access nationwide (The 19th) (KFF Health News).
4o
You said:
Where can I find the context of that transcribed?
ChatGPT said:
ChatGPT
You can find the context of Trump’s hints about reconsidering the FDA’s approval of mifepristone in the broader discussion of Project 2025 by referring to the articles from KFF Health News and The 19th News, which detail the proposals and the potential actions a future Trump administration might take regarding abortion.
Here are the links to those articles:
- KFF Health News – Inside Project 2025: Former Trump Official Outlines Hard Right Turn Against Abortion
- The 19th News – Trump Abortion Stance: What a Second Term Could Mean for Abortion Restrictions
These sources provide detailed insights into the strategies and considerations discussed within conservative circles for a potential Trump administration, including the reconsideration of mifepristone by the FDA.
4o
You said:
When was mifepristone approved by the FDA?
ChatGPT said:
ChatGPT
Mifepristone was approved by the FDA on September 28, 2000. The approval marked a significant moment in reproductive health, as mifepristone is one of the two drugs commonly used in medication abortions, often referred to as the “abortion pill.” The approval allowed mifepristone to be used in combination with misoprostol to terminate early pregnancies, typically up to 10 weeks.
The FDA’s decision was based on extensive research and clinical trials demonstrating the safety and effectiveness of mifepristone when used as directed. The drug has since become a central part of medication abortion practices in the United States.
You can find more detailed information on this in FDA archives and related medical literature.
4o
You said:
who makes Mifepristone and is there a generic alternative?
ChatGPT said:
ChatGPT
Mifepristone, originally known by the brand name Mifeprex, is manufactured by Danco Laboratories. Mifeprex was the first form of mifepristone approved by the FDA in 2000 for use in combination with misoprostol to terminate early pregnancies.
There is also a generic alternative to Mifeprex, which was approved by the FDA in April 2019. This generic version is produced by GenBioPro, Inc. Both the brand-name Mifeprex and the generic mifepristone are chemically identical and function in the same way to terminate early pregnancies.
The availability of a generic version can increase access by reducing costs and expanding distribution options (The 19th) (KFF Health News).
4o
You said:
So how many companies manufactured and sold Mifeprstone between 2000 and 2019?
ChatGPT said:
ChatGPT
Between 2000 and 2019, Danco Laboratories was the sole manufacturer and distributor of mifepristone (under the brand name Mifeprex) in the United States. Danco Laboratories held exclusive rights to the drug during this period, making it the only company providing mifepristone for medical abortions in the U.S.
In April 2019, a second company, GenBioPro, Inc., entered the market after the FDA approved their generic version of mifepristone. This approval marked the first time another company was authorized to manufacture and sell mifepristone, thus breaking Danco Laboratories’ exclusive hold on the market (The 19th).
So, from 2000 to 2019, only one company, Danco Laboratories, manufactured and sold mifepristone in the U.S.
4o
You said:
What would the estimated revenue be for that time period?
ChatGPT said:
ChatGPT
Estimating the revenue generated by Danco Laboratories from the sale of Mifepristone (Mifeprex) between 2000 and 2019 is challenging due to the lack of publicly available financial data specific to the company. Danco Laboratories is a privately held company, and detailed revenue information is not typically disclosed for private firms.
However, some estimates can be made based on the known usage of mifepristone in the United States. By 2017, it was reported that over 3 million women had used Mifeprex since its approval in 2000. According to various sources, the price of Mifeprex during this period generally ranged between $75 to $90 per dose, though the total cost of the medication when provided in a clinical setting could be higher due to additional fees associated with the procedure.
If we consider:
- An estimated average price of $82.50 per dose (midpoint between $75 and $90)
- Over 3 million doses sold by 2017
A rough estimate of the revenue from Mifeprex sales alone could be calculated as:Revenue=3,000,000 doses×$82.50 per dose=$247,500,000\text{Revenue} = 3,000,000 \text{ doses} \times \$82.50 \text{ per dose} = \$247,500,000Revenue=3,000,000 doses×$82.50 per dose=$247,500,000
This estimate suggests that Danco Laboratories might have generated approximately $247.5 million in revenue from the sale of Mifeprex by 2017. Extending this estimate to 2019 would increase the total slightly, but without precise data on the number of doses sold annually and the exact pricing, this remains a rough approximation.
Keep in mind, this estimate does not account for any variations in price over time, possible changes in demand, or costs associated with manufacturing, distribution, or regulatory compliance. Additionally, it only considers revenue from the U.S. market.
For a more precise figure, more detailed financial disclosures from Danco Laboratories would be necessary, but as a private company, such information is not typically available.
4o
You said:
By whom was the 3 million women number reported in 2017?
ChatGPT said:
ChatGPT
The figure of “over 3 million women” having used Mifepristone (Mifeprex) by 2017 was reported by the Guttmacher Institute, a leading research and policy organization committed to advancing sexual and reproductive health and rights. This statistic was often cited in discussions about the impact and prevalence of medication abortion in the United States.
Additionally, this number was echoed in reports by Danco Laboratories themselves, as well as various reproductive health organizations and advocacy groups that track and analyze abortion statistics. The figure was used to illustrate the widespread adoption and use of Mifeprex since its FDA approval in 2000.
For more detailed information, you can refer to reports by the Guttmacher Institute or directly check statements from Danco Laboratories around that period.
4o
You said:
Knowing how many abortions are performed in the US annually and after being told most are performed with this medication, that number seems very low.
ChatGPT said:
ChatGPT
You’re correct in questioning the figure, as it may seem low given the context of abortion statistics in the U.S. To clarify, the number of “over 3 million women” who used Mifepristone by 2017 was indeed reported, but let’s dive deeper into why that number might seem lower than expected.
Annual Abortion Statistics in the U.S.
According to the Guttmacher Institute and the Centers for Disease Control and Prevention (CDC), the number of abortions performed annually in the U.S. has fluctuated over the years. For example:
- In 2000, there were about 1.31 million abortions.
- By 2017, the number had decreased to about 862,320.
Usage of Mifepristone
Mifepristone, in combination with misoprostol, became increasingly popular over time as a method for early abortions. By 2017, medication abortions (which include the use of Mifepristone) accounted for about 39% of all abortions in the U.S., according to the Guttmacher Institute. This trend increased in subsequent years.
Reconciling the Numbers
Given the declining total number of abortions and the gradual adoption of medication abortion, the “over 3 million” figure reported by 2017 makes sense when considering the time it took for Mifepristone to become widely used. In the early 2000s, surgical abortion was still the dominant method. It wasn’t until later years that medication abortion, particularly with Mifepristone, became more prevalent.
Here’s how the figure aligns with overall abortion numbers:
- If Mifepristone was used in a growing percentage of the approximately 800,000 to 1.3 million annual abortions, reaching 3 million users over 17 years indicates a gradual increase in its adoption, but not an overwhelming majority of all abortions during that period.
Conclusion
While the figure might initially seem low, it’s important to remember that Mifepristone’s adoption grew over time, and it didn’t immediately become the primary method of abortion upon its approval. Additionally, the total number of abortions has been decreasing, which also impacts the total number of Mifepristone users.
For further details, you can review reports from the Guttmacher Institute and the CDC that provide comprehensive data on abortion trends.
4o
You said:
Understood. What is the average number of annual abortions performed in the US between 2000 and 2023
ChatGPT said:
ChatGPT
To calculate the average number of annual abortions performed in the U.S. between 2000 and 2023, we can consider data from reputable sources such as the Guttmacher Institute and the Centers for Disease Control and Prevention (CDC).
Data Overview:
- Early 2000s: The number of abortions was around 1.31 million in 2000.
- 2017: The number of abortions reported was about 862,320.
- Recent Trends: There has been a gradual decline in the number of abortions over the years, influenced by various factors, including changes in laws, access to contraception, and shifts in public attitudes.
Estimating the Average:
Using available data and considering that the numbers have gradually decreased over time, the average number of abortions annually from 2000 to 2023 can be estimated as follows:
- 2000-2010: Approximately 1.2 million per year (taking into account the slow decline from 1.31 million).
- 2011-2020: Approximately 900,000 per year (reflecting the continued decline).
- 2021-2023: The number likely continued to decrease or stabilize around 800,000 per year.
Calculating the Average:
Given these numbers, the estimated average annual number of abortions over this period can be calculated as:Average=(1.2 million×10)+(900,000×10)+(800,000×3)23\text{Average} = \frac{(1.2 \text{ million} \times 10) + (900,000 \times 10) + (800,000 \times 3)}{23} Average=23(1.2 million×10)+(900,000×10)+(800,000×3)Average=(12 million+9 million+2.4 million)23\text{Average} = \frac{(12 \text{ million} + 9 \text{ million} + 2.4 \text{ million})}{23}Average=23(12 million+9 million+2.4 million)Average≈987,000 per year\text{Average} \approx 987,000 \text{ per year}Average≈987,000 per year
Conclusion:
The estimated average number of annual abortions in the U.S. between 2000 and 2023 is approximately 987,000. This figure represents a rough average, considering the overall trend of declining abortion numbers during this period.
For the most accurate and detailed figures, consulting the Guttmacher Institute and CDC reports on abortion statistics would provide the most precise data.
4o
You said:
And extrapolating the increased adoption of this pill. What would that come to in 2023?
ChatGPT said:
ChatGPT
To estimate the number of abortions performed using mifepristone in 2023 by extrapolating from the increased adoption of the pill, we’ll consider several factors:
- Annual Abortion Trends:
- Between 2000 and 2023, the total number of abortions in the U.S. has been declining. By 2023, it’s reasonable to estimate that the total number of abortions might have been around 800,000 annually.
- Increasing Use of Medication Abortion:
- The use of mifepristone for medication abortions has increased significantly since its approval. By 2020, approximately 54% of all abortions in the U.S. were medication abortions, according to the Guttmacher Institute. This percentage has likely increased slightly by 2023, potentially reaching around 60%.
- Estimating the Number of Mifepristone Users in 2023:
- If 60% of the estimated 800,000 abortions in 2023 were medication abortions using mifepristone, the calculation would be as follows:
Mifepristone Users in 2023=800,000×0.60=480,000\text{Mifepristone Users in 2023} = 800,000 \times 0.60 = 480,000Mifepristone Users in 2023=800,000×0.60=480,000
Conclusion:
In 2023, approximately 480,000 abortions may have been performed using mifepristone, based on the increasing adoption rate and the overall decline in total abortion numbers.
Sources:
- Guttmacher Institute: Regularly tracks and reports on abortion trends, including the increasing use of medication abortions.
- Centers for Disease Control and Prevention (CDC): Provides annual abortion statistics in the U.S.
These organizations would provide the most reliable and updated data for further reading and more precise figures.
4o
You said:
At a cost of how much per treatment?
ChatGPT said:
ChatGPT
The cost of a mifepristone treatment in the United States varies depending on several factors, including the healthcare provider, location, and whether the medication is administered in a clinic or prescribed for at-home use. As of recent estimates:
- Mifeprex (Brand Name): The cost of the branded mifepristone (Mifeprex) typically ranges between $75 to $90 per pill. However, when you include the additional costs of a clinic visit, counseling, and follow-up care, the total cost for a medication abortion using mifepristone can range from $300 to $800.
- Generic Mifepristone: The introduction of the generic version by GenBioPro might slightly lower the cost per pill, but the overall cost for the patient often remains in a similar range due to the associated medical services required.
Estimating the Total Revenue for 2023:
If approximately 480,000 medication abortions were performed using mifepristone in 2023, and assuming an average treatment cost of $400 (midpoint of the range considering associated services), the total revenue generated from these treatments would be:Total Revenue=480,000×400=$192,000,000\text{Total Revenue} = 480,000 \times 400 = \$192,000,000Total Revenue=480,000×400=$192,000,000
Conclusion:
The estimated total revenue from mifepristone treatments in 2023 could be around $192 million. This figure includes the cost of the medication itself as well as related medical services.
For more precise costs, it’s best to refer to local clinics, Planned Parenthood, or other healthcare providers who offer these services, as prices can vary significantly based on location and healthcare provider policies.
4o